Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro

Keyphrases

• Adoptive Cell Therapy 100%
• Adoptive Immunotherapy 33%
• Antitumor 33%
• Apoptosis Markers 33%
• Cancer-associated Fibroblasts 66%
• Caspase-3 33%
• CD277 33%
• Complex Tumor 33%
• Cytotoxicity Assay 100%
• Functional Assessment 33%
• Heterogeneous Tumors 66%
• Imaging Systems 33%
• IncuCyte 33%
• Live Cell Imaging 33%
• Microenvironment 100%
• Patient-derived Organoids 66%
• Preclinical Development 33%
• Serum-free Medium 33%
• Solid Tumors 100%
• Supernatant 33%
• T Cells 33%
• Target Specificity 33%
• Targeted Cells 33%
• Therapy Efficacy 100%
• Three Dimensional Model 33%
• Three-dimensional (3D) 100%
• Three-dimensional Modeling 100%
• Tumor Cell Lysis 33%
• Tumor Cells 33%
• Tumor Microenvironment 100%
• Tumor Reactivity 33%
• Tumor Targeting 33%

Medicine and Dentistry

• Adoptive Immunotherapy 33%
• Cancer Associated Fibroblast 33%
• Caspase 3 33%
• Cell Therapy 100%
• Cytolysis 33%
• Cytotoxicity Assay 100%
• Fibroblast 33%
• Health Care Cost 33%
• Immunotherapy 66%
• In Vitro 100%
• Live Cell Imaging 33%
• Neoplasm 100%
• Organoid 66%
• Programmed Cell Death 33%
• Secretion (Process) 33%
• Solid Malignant Neoplasm 100%
• T Cell 100%
• T Cell Receptor 33%
• Tumor Cell 66%
• Tumor Microenvironment 100%
• Tumor Spheroid 33%

Immunology and Microbiology

• Adoptive Immunotherapy 33%
• Cancer Associated Fibroblast 33%
• Caspase 33%
• Cytolysis 33%
• Cytotoxicity 100%
• Fibroblast 33%
• Immunotherapy 66%
• Organoid 66%
• Preclinical Study 33%
• Secretion (Process) 33%
• Supernatant 33%
• T Cell 100%
• T Cell Receptor 33%
• Tumor Cell 66%
• Tumor Spheroid 33%